• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

by Fred Pennic 09/29/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– A new KLAS Flash Insights report explores how Epic’s  native clinician-facing ambient AI speech tool has the potential to reshape the market.  

– Initially, Epic provided ambient speech through integrations with partners like Microsoft and Abridge. However, at its annual UGM in August 2025, Epic announced its own native clinician-facing ambient speech tool, developed with Microsoft. 

– To understand the industry reaction, KLAS interviewed 35 Epic customers who attended UGM, prompting leaders to reassess their roadmaps and vendor strategies. 

Most Customers Welcome Epic’s Entry, Awaiting Maturity

Excitement around artificial intelligence (AI), particularly ambient speech, has surged as healthcare organizations seek to improve operations and reduce clinician burden. In response to this demand, the market has rapidly grown.  The announcement of an Epic-native AI tool was largely anticipated by customers. 

Overall, 67% of interviewed leaders reacted positively. They expressed confidence that Epic’s tool will eventually offer stronger integration and a lower price point than competing ambient speech solutions. Only a small minority expressed frustration, with one feeling Epic had wasted their time by encouraging work with a partner only to develop a competing product. For most, the prevailing question is how quickly Epic can deliver a tool that matches the maturity of current solutions.


Pressure on Vendors and Near-Term Adoption Plans

Epic’s large presence in healthcare IT is viewed as both a benefit and a drawback. While some worry Epic’s expanding portfolio may reduce competition, others hope the added pressure on incumbent vendors will spur them to accelerate innovation and expand functionality.

Most interviewed organizations anticipate adopting Epic’s ambient speech tool within the next two years. This confidence is driven by satisfaction with and investment in Epic. For many, the prospect of consolidation and native integration with the full patient record is compelling. Organizations without a current ambient solution also expect to adopt Epic’s tool quickly.

However, adoption may be slowed by:

  • Existing contracts with other ambient vendors.
  • Concerns about the new solution’s maturity and functionality compared to existing tools.

Long-Term Outlook Favors Epic Exclusivity

Looking further ahead, most respondents expect Epic to eventually become their exclusive ambient solution. This mirrors historical patterns where customers prioritize Epic’s perceived integration and cost advantages over concerns about early functionality gaps.

Specifically, Microsoft customers express the highest confidence in moving to Epic exclusively, largely due to Microsoft’s involvement in the tool’s development. Customers of other vendors are generally more cautious, waiting for Epic to demonstrate system maturity, particularly regarding specialty support and functionality beyond basic note generation.

Ultimately, the long-term strategy for many will be a mixed approach: deploying Epic’s tool where it fits best while retaining other specialized ambient tools to meet specific specialty needs.

“When Epic’s solution is ready for prime time, we will likely look to replace our current solution. I feel bad for our current vendor, but it is hard to compete with Epic when they have all the native integrations and access to the entire record. Working with Epic becomes a no-brainer, but the question is how long it will take until Epic ambient voice is ready.” —Senior directorFor more information about the report, visit https://klasresearch.com/report/epic-s-ambient-speech-announcement-2025-how-epic-s-move-into-ambient-speech-may-shape-customer-strategies/3920

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, KLAS

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |